<bill session="116" type="s" number="1897" updated="2022-11-01T13:51:01Z">
  <state datetime="2019-06-19">REFERRED</state>
  <status>
    <introduced datetime="2019-06-19"/>
  </status>
  <introduced datetime="2019-06-19"/>
  <titles>
    <title type="display">A bill to establish a process for updating the labeling of certain drugs with outdated labeling.</title>
    <title type="official" as="introduced">A bill to establish a process for updating the labeling of certain drugs with outdated labeling.</title>
  </titles>
  <sponsor bioguide_id="B001267"/>
  <cosponsors>
    <cosponsor bioguide_id="E000285" joined="2019-06-19"/>
  </cosponsors>
  <actions>
    <action datetime="2019-06-19">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-06-19" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="5668" relation="unknown"/>
    <bill session="116" type="s" number="1895" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-07T14:24:36Z" status="Introduced in Senate">This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.</summary>
</bill>
